Huahui Health
Clinical trials sponsored by Huahui Health, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cancer drug HH160 enters first human tests for advanced tumors Results expected Aug 2027 (estimated)
-
New hope for hepatitis d: libevitug enters final testing phase
Disease control Recruiting nowThis Phase 3 trial is testing a new drug called libevitug in 160 people with chronic hepatitis D, a serious liver infection. The goal is to see if libevitug can lower the virus in the blood and improve liver health. Participants receive the drug by IV infusion, and the study comp…
Phase 3 • Sponsor: Huahui Health • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New cancer drug HH160 enters first human tests for advanced tumors
Disease control Recruiting nowThis early-stage study tests a new drug called HH160 in about 56 adults with advanced solid tumors (cancers that have spread). The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. Participants will receive HH160 alone or with other cancer tr…
Phase 1 • Sponsor: Huahui Health • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New shot aims to tame hepatitis b virus
Disease control Recruiting nowThis study tests a new biologic drug called HH-006 in 45 adults with chronic hepatitis B. Participants receive injections for 48 weeks, and researchers track how well the drug lowers hepatitis B surface antigen (HBsAg) levels. The goal is to see if the drug can control the infect…
Phase 2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for liver cancer: experimental drug HH-009 enters human trials
Disease control Recruiting nowThis study tests a new drug called HH-009 in people with advanced liver cancer that has worsened after other treatments. About 30 participants will receive one of two doses to see if it can slow or stop cancer growth. The goal is to find out if the drug is safe and effective.
Phase 1/2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC